Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center
About this trial
This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.
Eligibility criteria
Qualifiers
Adults with medication-refractory focal epilepsy who have undergone RNS implantation at least six months prior and are in the judgement of the treating physician on a stable RNS regimen in terms of stimulation
Willing to attend all study visits and complete all required study procedures
Access to private or public wireless data service at regular intervals
Access to personal mobile device
Disqualifiers
Documentation of a musicogenic, or auditory-triggered focal seizure semiology
Participant is unable to reasonably participate in study tasks as determined by the investigator
Inability to obtain informed consent from the patient or legally authorized representative
Trial design
Treatments tested in this trial
- Experimental Intervention (Music A)
- Active Comparator Intervention (Music B)
- Active Comparator Intervention (Music C)
Treatment groups
24 Participants
are divided into 3 treatment groupsSponsors and collaborators
Dartmouth-Hitchcock Medical Center
Lead sponsor
Dartmouth College
Collaborator
University of Massachusetts, Worcester
Collaborator
Source ClinicalTrials.gov